Hypoglycemic and hypolipidemic effects of a novel dual peroxisome proliferator-activated receptor (PPAR) alpha/gamma agonist, E3030, in db/db mice

被引：0
|
作者：
Inoue, T
Yoshitomi, H
Kasai, S
Hihara, T
Matsuura, F
Shinoda, M
Saeki, T
Tanaka, I
机构：
来源：
DIABETES | 2004年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A129 / A129
页数：1
相关论文
共 50 条
  • [11] Treatment of Mitochondrial Diabetes with a Peroxisome Proliferator-activated Receptor (PPAR)-gamma Agonist
    Ninomiya, Hiroyo
    Hirata, Ayumu
    Kozawa, Junji
    Nakata, Shinsuke
    Kimura, Takekazu
    Kitamura, Tetsuhiro
    Yasuda, Tetsuyuki
    Otsuki, Michio
    Imagawa, Akihisa
    Kaneto, Hideaki
    Funahashi, Tohru
    Shimomura, Iichiro
    INTERNAL MEDICINE, 2016, 55 (09) : 1143 - 1147
  • [12] Safety, tolerability and pharmacokinetics of E3030, a novel PPAR alpha/gamma dual agonist, in Japanese healthy male subjects
    Takeuchi, Yutaka
    Nishioka, Yuki
    Kitahara, Yasumi
    Hasegawa, Setsuo
    Ohnishi, Akihiro
    DIABETES, 2006, 55 : A145 - A145
  • [13] P633H, a novel dual agonist at peroxisome proliferator-activated receptors α and γ, with different anti-diabetic effects in db/db and KK-Ay mice
    Chen, Wei
    Zhou, Xin-Bo
    Liu, Hong-Ying
    Xu, Cheng
    Wang, Li-Li
    Li, Song
    BRITISH JOURNAL OF PHARMACOLOGY, 2009, 157 (05) : 724 - 735
  • [14] Muraglitazar, a novel dual (α/γ) peroxisome proliferator-activated receptor activator, improves diabetes and other metabolic abnormalities and preserves β-cell function in db/db mice
    Harrity, T
    Farrelly, D
    Tieman, A
    Chu, CX
    Kunselman, L
    Gu, LQ
    Ponticiello, R
    Cap, M
    Qu, FC
    Shao, CN
    Wang, W
    Zhang, H
    Fenderson, W
    Chen, S
    Devasthale, P
    Jeon, Y
    Seethala, R
    Yang, WP
    Ren, J
    Zhou, M
    Ryono, D
    Biller, S
    Mookhtiar, KA
    Wetterau, J
    Gregg, R
    Cheng, PT
    Hariharan, N
    DIABETES, 2006, 55 (01) : 240 - 248
  • [15] Comparison of vascular relaxation, lipolysis and glucose uptake by peroxisome proliferator-activated receptor-γ activation in +db/+m and +db/+db mice
    Seto, Sai Wang
    Lam, Tsz Yan
    Leung, George P. H.
    Au, Alice L. S.
    Ngai, Sal Ming
    Chan, Shun Wan
    Kwan, Yiu Wa
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 572 (01) : 40 - 48
  • [16] Metaglidasen, a novel selective peroxisome proliferator-activated receptor-γmodulator, preserves pancreatic islet structure and function in db/db mice
    Zhang, Fang
    Clemens, L. Edward
    Gregoire, Francine M.
    Wilson, Maria
    Gelling, Richard W.
    Udove, Judith
    Tang, James
    Gustafson, Thomas A.
    DIABETES, 2006, 55 : A326 - A326
  • [17] Peroxisome proliferator-activated receptor gamma (PPARγ) as a novel target for prostate cancer
    Smith, MR
    Kantoff, PW
    INVESTIGATIONAL NEW DRUGS, 2002, 20 (02) : 195 - 200
  • [18] Peroxisome Proliferator-Activated Receptor Gamma (PPARγ as a Novel Target for Prostate Cancer
    Matthew R. Smith
    Philip W. Kantoff
    Investigational New Drugs, 2002, 20 : 195 - 200
  • [19] Safety, tolerability, and pharmacokinetics of CKD-501, a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist
    Shin, Sang-Goo
    Kim, Jung-Ryul
    Cho, Joo-Youn
    Lim, Kyoung Soo
    Kim, JaeWoo
    Kim, Bo-Hyung
    Shin, Hyun Suk
    Yu, Kyung-Sang
    Shin, Jae-Soo
    Ahn, Soon-Kil
    Jang, In-Jin
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 200 - 200
  • [20] Novel Dual-ACTING PEROXISOME Proliferator-Activated Receptor Alpha and Gamma Agonists.
    Sharma, R.
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2008, 2 (01) : 659 - 667
12345